Alexander Pedenko - Electromedical Technologies Chief Advisor

All Insiders . USA . 
Stock . Electromedical Technologies . Stakeholders . Insider . Alexander Pedenko
EMED Stock  USD 0.0003  0.0001  25.00%   

Insider

Alexander Pedenko is Chief Advisor of Electromedical Technologies
Phone480 292 8976
Webhttps://www.electromedtech.com

Electromedical Technologies Management Efficiency

The company has return on total asset (ROA) of (1.3631) % which means that it has lost $1.3631 on every $100 spent on assets. This is way below average. Electromedical Technologies' management efficiency ratios could be used to measure how well Electromedical Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
Electromedical Technologies currently holds 673.28 K in liabilities. Electromedical Technologies has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Electromedical Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Electromedical Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Electromedical Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Electromedical to invest in growth at high rates of return. When we think about Electromedical Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Willem AppeloKoninklijke Philips NV
60
Nitin GoyalZimmer Biomet Holdings
N/A
Todd BrintonEdwards Lifesciences Corp
N/A
Nitin MDZimmer Biomet Holdings
N/A
Christopher ScogginsAbbott Laboratories
54
A HarrisonKoninklijke Philips NV
57
Brett WallMedtronic PLC
58
Rachel EllingsonZimmer Biomet Holdings
54
Andrea WainerAbbott Laboratories
55
Alejandro WellischAbbott Laboratories
49
Sreelakshmi KolliZimmer Biomet Holdings
46
Kevin LoftonMedtronic PLC
65
Carrie NicholZimmer Biomet Holdings
40
Sock ChuaKoninklijke Philips NV
63
Charles BrynelsenAbbott Laboratories
63
Sally SabaMedtronic PLC
N/A
Philip BoudreauAbbott Laboratories
51
Christopher TothSiemens Healthineers AG
44
Daveen ChopraEdwards Lifesciences Corp
45
Spencer StilesStryker
47
Randel WoodgriftAbbott Laboratories
59
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company was founded in 2002 and is headquartered in Scottsdale, Arizona. Electromedical Technologies operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 7 people. Electromedical Technologies [EMED] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Return On Asset-1.36

Electromedical Technologies Leadership Team

Elected by the shareholders, the Electromedical Technologies' board of directors comprises two types of representatives: Electromedical Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Electromedical. The board's role is to monitor Electromedical Technologies' management team and ensure that shareholders' interests are well served. Electromedical Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Electromedical Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Matthew Wolfson, President, CEO
Petar Gajic, CIO Technology
Cindy Solovei, Chief Advisor
Tad Mailander, Counsel
Kathy RN, Director Training
Alexander Pedenko, Chief Advisor

Electromedical Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Electromedical Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset-1.36
Operating Margin(2.94) %
Current Valuation3.49 M
Shares Outstanding172.88 M
Shares Owned By Insiders11.80 %
Price To Sales1.53 X
Revenue907.36 K
Gross Profit708.13 K
EBITDA(5.14 M)
Net Income(8.48 M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Other Information on Investing in Electromedical Pink Sheet

Electromedical Technologies financial ratios help investors to determine whether Electromedical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Electromedical with respect to the benefits of owning Electromedical Technologies security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY